文献速递银屑病与炎症性皮肤病

FOXE1通过调控WNT5A参与银屑病发病

FOXE1 Contributes to the Development of Psoriasis by Regulating WNT5A.
PubMed 文献 · J Invest Dermatol · 2023-06-30

该研究显示FOXE1在银屑病患者皮损、咪喹莫特诱导的小鼠模型及M5刺激的角质形成细胞中表达升高。FOXE1可能通过促进G1/S转换和激活ERK1/2信号通路促进角质形成细胞增殖,并减少IL-1β、IL-6和TNF-α产生。RNA测序鉴定WNT5A为潜在下游效应分子,敲低FOXE1可改善小鼠银屑病样皮炎症状。

要点

  • FOXE1在银屑病皮损、小鼠模型及M5刺激的角质形成细胞中表达升高。
  • FOXE1可能通过促进G1/S转换和激活ERK1/2信号通路促进角质形成细胞增殖。
  • 敲低FOXE1可减少角质形成细胞产生IL-1β、IL-6和TNF-α,并改善小鼠银屑病样皮炎。

核心结论

  • FOXE1参与银屑病发病,可作为银屑病治疗的靶点。

研究设计与样本

  • 研究比较银屑病患者皮损与非皮损皮肤中FOXE1表达,并采用咪喹莫特诱导的银屑病样小鼠模型及M5刺激的角质形成细胞。
  • 通过敲低和过表达FOXE1研究其功能,利用RNA测序鉴定下游效应分子,并通过慢病毒递送shRNA或遗传学方法耗竭FOXE1。

主要发现

  • FOXE1在银屑病患者皮损中的表达高于非皮损皮肤,在咪喹莫特诱导的小鼠模型及M5刺激的角质形成细胞中表达也升高。
  • FOXE1可能通过促进G1/S转换和激活ERK1/2信号通路促进角质形成细胞增殖。
  • 敲低FOXE1减少角质形成细胞产生IL-1β、IL-6和TNF-α。
  • RNA测序鉴定WNT5A为FOXE1的潜在下游效应分子;敲低WNT5A抑制角质形成细胞增殖、减少IL-1β、IL-6和TNF-α产生,并减轻FOXE1过表达角质形成细胞的促生长效应。
  • 通过慢病毒递送shRNA或遗传学方法耗竭FOXE1可改善咪喹莫特诱导的银屑病样小鼠模型的皮炎症状。

临床怎么用

  • FOXE1可能作为银屑病治疗的靶点。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Psoriasis is a common, chronic, and relapsing inflammatory skin disease characterized by hyperproliferation of keratinocytes (KCs) and infiltration of immune cells. The pathogenesis of psoriasis is complex, and the exact mechanism remains partially understood. In this study, we showed that the forkhead box family protein, FOXE1, had increased expression in lesional skins compared with nonlesional skin from patients with psoriasis. FOXE1 expression was also increased in an imiquimod-induced psoriatic mouse model as well as in M5-stimulated KCs. Using combinational approaches of knockdown and overexpression of FOXE1, we demonstrated that FOXE1 may promote the proliferation of KCs by facilitating G1/S transition and activating extracellular signal-regulated kinase 1/2 signaling pathway. In addition, knockdown of FOXE1 reduced the production of IL-1β, IL-6, and TNF-α by KCs. RNA-sequencing profiling identified WNT5A as a potential downstream effector of FOXE1. Knockdown of WNT5A inhibited the proliferation of KCs; reduced the production of IL-1β, IL-6, and TNF-α by KCs; and mitigated the growth-promoting effect of FOXE1 in FOXE1-overexpressed KCs. Finally, depletion of FOXE1 by lentiviral delivery of small hairpin RNAs or genetic approach ameliorated dermatitis symptoms in imiquimod-induced psoriasis-like mouse models. Taken together, our results indicated that FOXE1 participates in the pathogenesis of psoriasis and can serve as a target of psoriasis treatment.

来源:J Invest Dermatol,查看原文。版权归原作者所有。

引用

  1. Liu M, Zhang G, Wang Z, et al. FOXE1 Contributes to the Development of Psoriasis by Regulating WNT5A. J Invest Dermatol. 2023. PMID: 37394057. doi:10.1016/j.jid.2023.04.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。